Both activated ACK1 (pY284-ACK1 or pACK1) and AR levels increases as prostate cancer progresses from the benign prostatic hyperplasia (BPH) to the late stages of prostate cancer including the metastatic stage28,59. This evidence concerns the gene TNK2 and Familial prostate cancer.